Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 03/29 10:14:59 pm
108.01 USD   +20.45%
03/29 Dave & Buster's declines while Vertex Pharmaceuticals jumps
03/29 VERTEX PHARMACE : (VRTX) Spikes on Release of Two Studies
03/29 NASDAQ 100 MOVE : Biib, vrtx
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 2 150 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals1,032100%1,702100% +64.89%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States763.3273.9%1,32277.7% +73.17%
Europe219.6021.3%320.4618.8% +45.93%
Other49.424.8%59.913.5% +21.22%
Managers
NameAgeSinceTitle
Jeff Leiden612009Chairman, President & Chief Executive Officer
Ian F. Smith512001EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz, MD612014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD522012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD661989Director
Bruce I. Sachs, MBA571998Lead Independent Director
Elaine S. Ullian691997Lead Independent Director
Margaret G. McGlynn, MBA572011Independent Director
Terrence C. Kearney, MBA622011Independent Director
Yuchun Lee, MBA512012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 248,438,127 246,584,667 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 21,860,325 8.80%
Capital Research & Management Co. (World Investors) 20,758,133 8.36%
Fidelity Management & Research Co. 19,506,583 7.85%
The Vanguard Group, Inc. 15,914,094 6.41%
Wellington Management Co. LLP 14,920,158 6.01%
BlackRock Fund Advisors 13,350,517 5.37%
SSgA Funds Management, Inc. 11,774,161 4.74%
ClearBridge Investments LLC 8,649,358 3.48%
Columbia Management Investment Advisers LLC 7,775,790 3.13%
JPMorgan Investment Management, Inc. 7,339,008 2.95%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 3,186,5868.00%75,617,686 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..21.72%22 277
AMGEN, INC.12.65%121 301
CELGENE CORPORATION7.50%96 802
GILEAD SCIENCES, INC.-6.30%87 716
REGENERON PHARMACEUTIC..4.21%40 581
ACTELION LTD24.40%29 800
GENMAB A/S17.90%12 376
TESARO INC15.18%8 307
EXELIXIS, INC.42.72%6 190
BIOVERATIV INC0.00%5 630
HUALAN BIOLOGICAL ENGI..--.--%4 887
TONGHUA DONGBAO PHARMA..-2.46%4 414
KITE PHARMA INC75.31%4 310
BLUEBIRD BIO INC47.81%3 725
NEUROCRINE BIOSCIENCES..7.60%3 627
BIOCON LTD19.39%3 512
CLOVIS ONCOLOGY INC50.97%2 993
INTERCEPT PHARMACEUTIC..6.57%2 875
ULTRAGENYX PHARMACEUTI..-3.77%2 823
PEPTIDREAM INC-9.70%2 804
CHINA BIOLOGIC PRODUCT..-7.34%2 708
Sector Bio Therapeutic Drugs
Vertex Pharmaceuticals Inc : Connections
GreatCall, Inc.
WGBH Educational Foundation
Institute of Chartered Accountants in England & Wales
The Hastings Center
The Financial Executives Institute
Accelerated Cure Project for Multiple Sclerosis
Massachusetts Mutual Life Insurance Co.
The American Institute of Certified Public Accountants
Infectious Diseases Society of America
The Alliance for Business Leadership
The American Society for Clinical Pharmacology & Therapeutics
Massachusetts Life Sciences Center
Vertex Pharmaceuticals
SimpliVity Corp.
New England Aquarium Corp.
OneCloud Software, Inc.
Massachusetts Institute of Technology
The Brigham & Women's Hospital, Inc.
The Broad Institute, Inc.
Massachusetts Life Sciences Collaborative
Whitehead Institute for Biomedical Research
Museum of Science
American Society for Clinical Investigation
Massachusetts Workforce Board Association
The Boston Private Industry Council, Inc.
Nantero, Inc.
American Academy of Arts & Sciences
SpiderCloud Wireless, Inc.
Macp Organization
DataGravity, Inc.
Charles River Ventures, Inc.
Jibo, Inc.
Institute of Medicine
iControl Networks, Inc.
Clarabridge, Inc.
Biotechnology Innovation Organization
Association of American Physicians
Abington Friends School
Alkeus Pharmaceuticals, Inc.
New England Healthcare Institute
Orphan Technologies Ltd.
Harvard Medical School
Wesleyan University
Allego, Inc.
Celebrity Series of Boston, Inc.
General Catalyst Partners LLC
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem